Spain’s Natraceutical in Brazil expansion deal

MADRID, Oct 7 (Reuters) – Spanish food group Natraceutical (NATE.MC) said on Thursday it had made a deal with Brazil’s Bio Group to develop its Forte Pharma food supplements brand in that country, an agreement which may allow parent Natra to cut debt.

Natra, with market capitalisation of 96.38 million euros ($131.6 million), has an option to sell its 47 percent stake in Natraceutical via a share swap to Bio Group’s parent Davene at 0.43 euros per share, cutting debt “significantly”, the statement said.

It is also contemplating the possibility of a Brazilian listing for Natraceutical.

Davene also has the option to buy Natra’s around 4 percent stake in France’s Naturex (NATU.PA) at 35.3 euros per share.

Shares in Natra and Natraceutical, suspended earlier, will reopen after 0830 GMT. They closed on Wednesday at 0.369 euros and 2.030 euros respectively. ($1=.7322 Euro) (Reporting by Elisabeth O’Leary; Editing by Hans Peters)

 

Advertisements

About Hildete Vodopives

Hildete de Moraes Vodopives is founder of Brazil Global and of the Harvard Strategists Bureau. She is a member of the Brazilian Investment Analysts Association (APIMEC-Rio) where she served as Corporate Relations Director and later, on the board. Hildete advises companies doing business in Brazil. She lives between Paris and Rio and is a member of the Harvard Club of Paris and of the Mercosur Women’s Forum.
This entry was posted in Business, Investment and tagged , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s